Adduction spastic dysphonia: Clinic and treatment;Disfonía espástica de aducción: Clínica y tratamiento

Revista Clinica Espanola

Volumn 198, Issue 3, 1998, Pages 156-158

  Garcia Ruiz P J ^a,b   Sanchez Del Rio M ^a   Cenjor Espanol C ^b   Sanabria Brassart, J ^b   Sanchez Bernardos V ^a   Astarloa Gomez R ^a   Garcia De Yebenes J ^a  

^a Fund Jiménez Díaz   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Focal dystonia; Spastic dysphonia

Indexed keywords

ANTIPARKINSON AGENT; BOTULINUM TOXIN;

ADULT; ARTICLE; DYSTONIA; FEMALE; HUMAN; LARYNX DISORDER; MALE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DYSTONIA; FEMALE; HUMANS; MALE; MIDDLE AGED; VOICE DISORDERS;

EID: 0032019408     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jankovic J. Fahn S Dystonic disorders. En: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore: Williams & Wilkins, 1993; 337-374.
2. Ludlow CL. The spasmodic dysphonias: speech movement, and physiological characteristics. En: King J, Tsui C, Calne DB, eds Handbook of dystonia. New York: Marcel Dekker, 1995; 159-180.
3. Miller R, Woodson G, Jankovic J. Botulinum toxin injection of the vocal fold for spasmodic dysphonia Arch Otolaryngol Head Neck Surgery 1987; 113:603-605.
4. Critchley M. Spastic disphonia. Brain 1939; 62:96-103.
5. Brin M, Blitzer A, Fahn S, Lovelace R Localized injections of botulinum toxin for the treatment of local laryngeal dystonia. Laryngoscope 1988; 98:193-197
6. Lees AJ, Turjenski N, Rivest J, Whurr R, Lorch M, Brookes G Treatment of cervical dystonia. hand spasm and laryngeal dystonia with botulinum toxin J Neurol 1992; 239 1-4
7. Brin MF, Blitzer A, Stewart A, Diamond B. Lovelace RE Botulinum toxin for spasmodic dysphonia. double blind placebo controlled assessment of dose and technique Mov Disord 1995; 10:369
8. Ford C, Bless D, Lowery J. Indirect laryngoscopic approach for injection of botulinum toxin in spamodic dysphonia. Otolaryngol Head Neck Surgery 1990; 103 752-758
9. Ohly AK, Ceballos Baumann AO, Joussen K, Conrad B Adductor type laryngeal dystonia. a series with botulinum toxin therapy using transoral injections. Mov Disord 1995: 10 400
10. Whurr R, Lorch M, Fontana H, Brookes G, Lees A, Marsden CD. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia. J Neurol Neurosurg Psychiatry 1993; 56:526-530
11. Garcia Ruiz PJ, Cenjor Español C, Sánchez Pernaute R, Astarloa R, Sánchez Bernardos V, García de Yébenes Prous J. Distonía laringea Tratamiento con toxina botulinica mediante técnica transcutánea y transoral. Estudio comparative. Neurologia 1996; 11:216-219.
12. Sapir S. Psychogenic spasmodic dysphonia: a case study with expert opinions. J Voice 1995; 9:270-281.
13. Jankovic J. Ford J Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983; 13:402-411
14. Grandas F, Elston J, Quinn N, Marsden CD. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 1988; 51:767-772.
15. King J, Tsui C, Cervical dystonia. En: King J, Tsui C, Caine DB, eds. Handbook of dystonia. New York: Marcel Dekker, 1995; 115-127.
16. Marsden, The focal dystonias. Clin Neuropharmacol 1986; 9 (suppl): 49-60
17. Bressman S. De León D, Brin MF, et al. Idiopathic dystonia among ashkenazi jews: evidence for autosomal dominant inheritance. Ann Neurol 1989; 26:612-020.
18. Fletcher NA, Harding AE, Marsden CD. A case control study of idiopathic torsion dystonia Mov Disord 1991; 4:304-309.
19. Chan J, Brin M, Fhan S Idiopathic cervical dystonia: clinical characteristics Mov Disord 1991; 2:119-126
20. Waddy HM, Fletcher NA, Harding A, Marsden CD. A genetic study of idiopathic focal dystonias. Ann Neurol 1991; 29:320-324.
21. Bressman S, Heiman GA, Nygaard TC, et al. A study of idiopathic torsion dystonia in a non Jewish family. Neurology 1994; 44:283-287.
22. Garcia Ruiz PJ, Sanchez V, Díaz Neira W, Astarloa R. Garcia de Yébenes J. Cervical dystonia: gender as a prognostic factor for Botulinum toxin treatment. European J of Neurology 1995; 1:68-69.
23. Stojanovic M, Cvtkovic D, Kostic VS A genetic study of idiopathic focal dystonias J of Neurology 1995; 242-508-511.
24. Brin MF, Stewart C, Blitzer A, Diamond B. Laryngeal botulinum toxin injections for disabling stuttering in adults. Neurology 1994; 44:2.262-2.266.
25. Kiziltan G, Akalin MA. Stuttering may be a type of action dystonia Mov Disord 1996; 3:278-282